Literature DB >> 19026023

Randomized controlled trials and assessment of drug safety.

David W J Clark, David M Coulter, Frank M C Besag.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 19026023     DOI: 10.2165/0002018-200831120-00002

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  14 in total

Review 1.  Detection, verification, and quantification of adverse drug reactions.

Authors:  Bruno H Ch Stricker; Bruce M Psaty
Journal:  BMJ       Date:  2004-07-03

2.  Prioritizing children's medicines for research: a pharmaco-epidemiological study of antiepileptic drugs.

Authors:  Ruth Ackers; Macey L Murray; Frank M C Besag; Ian C K Wong
Journal:  Br J Clin Pharmacol       Date:  2007-01-25       Impact factor: 4.335

3.  Ezetimibe and cancer--an uncertain association.

Authors:  Jeffrey M Drazen; Ralph B D'Agostino; James H Ware; Stephen Morrissey; Gregory D Curfman
Journal:  N Engl J Med       Date:  2008-09-02       Impact factor: 91.245

Review 4.  Prescription-event monitoring--recent progress and future horizons.

Authors:  R D Mann
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

5.  A Bayesian neural network method for adverse drug reaction signal generation.

Authors:  A Bate; M Lindquist; I R Edwards; S Olsson; R Orre; A Lansner; R M De Freitas
Journal:  Eur J Clin Pharmacol       Date:  1998-06       Impact factor: 2.953

6.  Severe persistent visual field constriction associated with vigabatrin.

Authors:  T Eke; J F Talbot; M C Lawden
Journal:  BMJ       Date:  1997-01-18

7.  Characteristics of a unique visual field defect attributed to vigabatrin.

Authors:  J M Wild; C Martinez; G Reinshagen; G F Harding
Journal:  Epilepsia       Date:  1999-12       Impact factor: 5.864

8.  Cough associated with captopril and enalapril.

Authors:  D M Coulter; I R Edwards
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

9.  Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  J French; M Smith; E Faught; L Brown
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

10.  The New Zealand intensive medicines monitoring programme in pro-active safety surveillance.

Authors:  D M Coulter
Journal:  Pharmacoepidemiol Drug Saf       Date:  2000-07       Impact factor: 2.890

View more
  2 in total

1.  Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches.

Authors:  Guillermo Prada-Ramallal; Bahi Takkouche; Adolfo Figueiras
Journal:  Drug Saf       Date:  2017-07       Impact factor: 5.606

2.  Review of quality assessment tools for the evaluation of pharmacoepidemiological safety studies.

Authors:  George A Neyarapally; Tarek A Hammad; Simone P Pinheiro; Solomon Iyasu
Journal:  BMJ Open       Date:  2012-09-25       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.